Endoscopic ultrasound-guided radiofrequency ablation in gastroenterology: New horizons in search

World J Gastroenterol. 2017 Jul 21;23(27):4892-4896. doi: 10.3748/wjg.v23.i27.4892.

Abstract

Radiofrequency ablation (RFA) has been widely used for the treatment of various solid organ malignancies. Over the last decade, endosonographers have gradually shifted the application of RFA from porcine models to humans to treat a spectrum of diseases. RFA is performed in patients with pancreatic carcinoma who are not candidates for surgery. In this paper, we will discuss various indications for RFA, its procedural details and complications. At present, endoscopic ultrasound-guided RFA is gradually incorporated into the management of various diseases and opens a new avenue for disease treatment.

Keywords: Pancreatic carcinoma; Radiofrequency ablation.

Publication types

  • Review

MeSH terms

  • Animals
  • Catheter Ablation / adverse effects
  • Catheter Ablation / instrumentation
  • Catheter Ablation / methods*
  • Catheter Ablation / trends
  • Catheters
  • Disease Models, Animal
  • Electrodes
  • Endosonography / adverse effects
  • Endosonography / instrumentation
  • Endosonography / methods*
  • Endosonography / trends
  • Hot Temperature / adverse effects
  • Humans
  • Pancreas / diagnostic imaging
  • Pancreas / surgery
  • Pancreatic Neoplasms / diagnostic imaging
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / surgery*
  • Pancreatitis / etiology
  • Postoperative Complications / etiology
  • Survival Rate
  • Swine
  • Treatment Outcome
  • Ultrasonography, Interventional / adverse effects
  • Ultrasonography, Interventional / instrumentation
  • Ultrasonography, Interventional / methods*
  • Ultrasonography, Interventional / trends